271 related articles for article (PubMed ID: 34883206)
1. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
[TBL] [Abstract][Full Text] [Related]
6. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
7. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
Zhang K; Meng X; Yang Z; Dong H; Zhang X
Biomaterials; 2020 Nov; 258():120278. PubMed ID: 32781328
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of copper(Ⅱ)/diethyldithiocarbamate complex through tannic acid/copper(Ⅱ) network coated hollow mesoporous silica for enhanced cancer chemodynamic therapy.
Zhu Y; Wang N; Ling J; Yang L; Omer AM; Ouyang XK; Yang G
J Colloid Interface Sci; 2024 Apr; 660():637-646. PubMed ID: 38266345
[TBL] [Abstract][Full Text] [Related]
11. A cascade nanoplatform for the regulation of the tumor microenvironment and combined cancer therapy.
Hu X; Zhao W; Li R; Chai K; Shang F; Shi S; Dong C
Nanoscale; 2023 Oct; 15(40):16314-16322. PubMed ID: 37786260
[TBL] [Abstract][Full Text] [Related]
12. Smart Tumor Microenvironment-Responsive Nano-Prodrug for Disulfiram Toxification In Situ and the Exploration of Lethal Mechanisms in Cells.
Zhang Y; Qi G; Qu X; Wang B; Ma K; Jin Y
Langmuir; 2022 Jan; 38(1):584-592. PubMed ID: 34971310
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
14. Buffet-style Cu(II) for enhance disulfiram-based cancer therapy.
Zhao L; Wang X; Lou H; Jiang M; Wu X; Qin J; Zhang J; Guan X; Li W; Zhang W; Ma J
J Colloid Interface Sci; 2022 Oct; 624():734-746. PubMed ID: 35696791
[TBL] [Abstract][Full Text] [Related]
15.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
16. The construction of hierarchical assemblies with
Zhao WN; Li H; Sun S; Xu Y
J Mater Chem B; 2023 Nov; 11(46):11044-11051. PubMed ID: 37904545
[TBL] [Abstract][Full Text] [Related]
17. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
18. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
19. Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.
Wang S; Yin N; Li Y; Xiang T; Jiang W; Zhao X; Liu W; Zhang Z; Shi J; Zhang K; Guo X; Si P; Liu J
J Nanobiotechnology; 2022 Jul; 20(1):313. PubMed ID: 35794596
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment-Responsive Reagent DFS@HKUST-1 for Photoacoustic Imaging-Guided Multimethod Therapy.
Shen J; Zhou W; Jia M; Yang X; Lin J; An L; Tian Q; Yang S
ACS Appl Bio Mater; 2021 Jul; 4(7):5753-5764. PubMed ID: 35006738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
